Cancer Care Ontario | Cancer Care Ontario

79 Results

Guidelines and Advice

The Role of Amifostine as a Radioprotectant in the Management of Patients with Squamous Cell Head and Neck Cancer

Status: Archived
ID: 5-8

Apr 2012

Guidelines and Advice

Recommendations for Prophylactic Cranial Irradiation and Consolidative Radiation for Patients with Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance

Status: In-Review
ID: GL END 7-13-2
Version: 2

Nov 2019

Guidelines and Advice

Implementation Strategy for Radiation Therapy Safety Straps

Status: Current
ID: GL-C50-22

Oct 2015

Guidelines and Advice

Organizational Standards for the Delivery of Intensity Modulated Radiation Therapy (IMRT) in Ontario

Status: Archived
ID: 21-1

Apr 2010

Guidelines and Advice

The Use of Adjuvant Radiation Therapy for Curatively Resected Cutaneous Melanoma

Status: Current
ID: 8-9

Jan 2016

Guidelines and Advice

Biodegradable Rectal Spacers for Prostate Cancer Radiotherapy

Status: In-Review
ID: RR 21-5
Version: n/a

Jan 2019

Guidelines and Advice

Organizational Guideline for the Delivery of Stereotactic Radiosurgery for Brain Metastasis in Ontario

Status: Current
ID: 21-4
Version: N/A

Aug 2019

Guidelines and Advice

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Status: In-Review
ID: 3-22
Version: N/A

Apr 2020

Guidelines and Advice

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Status: Current

Oct 2019

Guidelines and Advice

Management of Early-Stage Hodgkin Lymphoma

Status: Current
ID: GL 6-20
Version: 2

May 2023

Guidelines and Advice

Locoregional Therapy of Locally Advanced Breast Cancer

Status: In-Review
ID: 1-19

Sep 2014

Guidelines and Advice

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Status: Education and Information
ID: 2-12
Version: 2

Oct 2013

The Role of Amifostine as a Radioprotectant in the Management of Patients with Squamous Cell Head and Neck Cancer

Recommendations for Prophylactic Cranial Irradiation and Consolidative Radiation for Patients with Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance

Implementation Strategy for Radiation Therapy Safety Straps

Organizational Standards for the Delivery of Intensity Modulated Radiation Therapy (IMRT) in Ontario

The Use of Adjuvant Radiation Therapy for Curatively Resected Cutaneous Melanoma

Biodegradable Rectal Spacers for Prostate Cancer Radiotherapy

Organizational Guideline for the Delivery of Stereotactic Radiosurgery for Brain Metastasis in Ontario

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Management of Early-Stage Hodgkin Lymphoma

Locoregional Therapy of Locally Advanced Breast Cancer

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Pages